AGAMREE

Santhera Expands AGAMREE Distribution Across Central Asia and Caucasus

PRATTELN, Switzerland, July 13, 2026 Santhera Pharmaceuticals announced the expansion of its exclusive distribution agreement with Biomedica, extending commercial...

By cGxPwire Editor
July 13, 2026

.Clinical

Santhera Reports Positive Phase 1 AGAMREE Data

Pratteln, Switzerland, July 1, 2026 Santhera Pharmaceuticals announced positive topline findings from a Phase 1 clinical study of AGAMREE®...

By cGxPwire Editor
July 6, 2026

M&A

Angelini Pharma to Acquire Catalyst Pharmaceuticals in $4.1 Billion Rare Disease Expansion Deal

ROME, Italy and CORAL GABLES, Florida, United States – May 7, 2026 Angelini Pharma S.p.A. and Catalyst Pharmaceuticals Inc....

By cGxPwire Editor
May 8, 2026

Bio-Pharma

Santhera Pharmaceuticals Gains EU Boost for AGAMREE Expansion

PRATTELN, Switzerland, April 27, 2026 Santhera Pharmaceuticals has achieved a significant regulatory milestone with the European Medicines Agency’s (EMA)...